Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

615.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 630.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.21m
  • Volume: 225,031
  • Market Cap: £739.27m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

Oxford Biomedica reiterates outlook as interim losses narrow

By Abigail Townsend

Date: Tuesday 23 Sep 2025

(Sharecast News) - Oxford Biomedica reiterated full-year guidance on Tuesday, after the biopharma saw strong demand throughout the first half and trimmed losses.

RBC Capital Markets raises target price on OXB

By Iain Gilbert

Date: Tuesday 26 Aug 2025

(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue guidance reiteration.

Oxford Biomedica raises £60m to bolster US capacity

By Benjamin Chiou

Date: Friday 15 Aug 2025

(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 615.00p
Change Today 19.00p
% Change 3.19 %
52 Week High 630.00p
52 Week Low 232.50p
Volume 225,031
Shares Issued 120.21m
Market Cap £739.27m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 03-Oct-2025

Time Volume / Share Price
16:47 3,678 @ 613.10p
16:35 4 @ 615.00p
16:35 1,026 @ 615.00p
16:35 55,961 @ 615.00p
16:35 276 @ 615.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page